chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea started 23 hours after the vaccine.  It has continued into day 3.  Slight nausea, but stomach mostly okay and has hunger.  Within 30min-1hr after eating, diarrhea occurs and continues. Sore arm Headache during the first 24 hours but this has resolved.
Pt stated itching over her neck, and then started to have minor wheezing. At 0900 vitals where taken and wheezing progressed. Then Benadryl was given 50 mg PO. At 0918 Pt was moved to Treatment Room. At 0935 an IV was administered and Solu Medrol 125 MG was given IV. At 0955 Pt was put on NRB oxygen at 15 lpm. No other treatments where administered and Pt was released at 1400. Pt was diagnosed with having an allergic reaction to Flu Mist.
Had vaccine too and got shingles/ suspected vaccination failure; Shingles; Slightly itchy spots; Minor backache; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had vaccine too and got shingles/ suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), pruritus (Verbatim: Slightly itchy spots) and back pain (Verbatim: Minor backache). The outcome of the vaccination failure was unknown and the outcome of the shingles, pruritus and back pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, pruritus and back pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pruritus and back pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 19-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and experienced shingles. The patient stated that the shingles were mild and they were no more than a minor problem. The patient had seven slightly itchy spots and minor backache. The patient reported that the vaccine lessened them considerably. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Pt presented to ER 22MAY PM w/hives & low grade temp 100.8; Given DPH;
clammy, diaphoretic, nausea. given ice pack, water, benadryl 25mg p.o. once 5 minutes after symptoms started at 5:48pm. v/s 124/98, 86, 97.0F, 18
pt had swollen lymphnode & pain in both arms & side of face was numb & tingling Numbness tingling, improved- after 2- 30 aep pt used heating pads & tye & helped. Pt still has occ pain in Neck comes and goes
Pt. rec'd PNEUMOVAX (L) deltoid on 9/19/13 and had just a local reaction with redness / soreness x 24 hrs. On 9/21 she developed a large swollen area down below (L) antecubital area to mid biceps - approx 10 cm area of cellulitis requiring BACTRIM.
Onset approximately 45 minutes to an hour after receiving, I began to feel very "swimmy" in my head,  like I  had consumed lot of alcohol in a short time. I felt a lot of pressure behind my nose, but not a stuffy nose. The woozy feeling also brought on some nausea. I felt like I couldn't focus, like I was in a daze or fog. This lasted throughout the following day. Left arm at sight of injection was sore starting 2 hours after shot, couldn't raise left arm x2 days. Still sore but manageable. I took a zofran for the nausea.
PER PATIENT SHE DEVELOPED A RASH ON FACE AND NECK THE EVENING THAT SHE RECEIVED SHINGRIX VACCINE.  PATIENT ALSO STATED THAT SHE DEVELOPED FLUID THAT SHE COUGH UP AND CONGESTION WHICH TURNED INTO BRONCHITIS.  VACCINE ADMINISTERED 3/5/19  BUT ADVERSE REACTION REPORTED 6/19/19.   HER PROVIDER DR ADVISED PATIENT NOT TO GET SECOND SHOT IN THE SERIES.
Patient was administered the flu vaccine in the left arm. The next day experienced localized soreness, pain to palpation, limited range of motion, and strength limited by pain. Symptoms have been ongoing to date 11/17/2021
Nine days after receiving the Moderna vaccine, I noticed rash and redness around vaccination site.   Rash and redness have persisted, and have grown larger, very itchy.
1/13/21-felt feverish (T=99.0), moderate HA, moderate arthralgias, moderate fatigue, mild BA, mild intermittent nausea. 1/14/21-moderate right axillary lymphadenopathy, mild right arm injection site pain, mild BA, mild nausea-lymphadenopathy impacted daily activities. Treated pain with Tylenol 1G, took twice over the course of the day. 1/15/21-felt feverish (T=98.8),  moderate right axillary lymphadenopathy, little impact on daily activities. Took Tylenol 1G once.  1/16/21-symptoms resolved.
Patient presented with 2 days of chest pain.  EKG showed mild diffuse elevations of ST segment. Cardiology consulted and Echo was normal. Cardiac markers were elevated but downtrended quickly.  Started on ibuprofen and chest pain resolved. No hemodynamic/respiratory compromise or arrhythmias. Ultimately diagnosed with myocarditis secondary to COVID vaccine booster. He continues to be followed by cardiology for periodic monitoring.
Immediately after being vaccinated, patient's face and eyes began to swell and became red. Patient denied itching or shortness of breath, itchy throat. Patient given 50mg benadryl at 1900. Patient then complained her throat was itchy and her voice was becoming hoarse. She continued to deny shortness of breath. EMS was called at 1908. EMS arrived at 1920, evaluated patient. Patient found to be stable and was given option to go to the hospital via EMS or go home. Patient decided to go home with her friends.
I woke up the following morning with a headache, sore muscles and joints and extreme fatigue.  By about 1:30pm, I took my temperature and had a low grade fever of 99.8.
Got 1 dose of moderna vaccine after completing the vaccination series with J&J vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Got 1 dose of moderna vaccine after completing the vaccination series with J&J vaccine) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Got 1 dose of moderna vaccine after completing the vaccination series with J&J vaccine). On 07-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (Got 1 dose of moderna vaccine after completing the vaccination series with J&J vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided.  On an unknown date in Mar-2021, the patient completed vaccination series with J & J COVID-19 vaccine.  On 07-Aug-2021, the patient was supposed to get COVID-19 test done. Instead of the COVID test, the patient got first dose of the moderna COVID-19 vaccine.  The patient was currently doing fine.
5 hrs. after shot arm was in extreme pain from end of clavicle to about 2 inches below on the arm. redness and swelling. Left arm
shoulder and neck pain in the mornings; muscle soreness; headaches; both of his ankles are swelling; fever for two days; elbow and wrist hurt for one day; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (shoulder and neck pain in the mornings), JOINT SWELLING (both of his ankles are swelling), ARTHRALGIA (elbow and wrist hurt for one day   ), PYREXIA (fever for two days) and MYALGIA (muscle soreness) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced ARTHRALGIA (elbow and wrist hurt for one day   ). On 21-May-2021, the patient experienced PYREXIA (fever for two days). On 26-May-2021, the patient experienced JOINT SWELLING (both of his ankles are swelling). On an unknown date, the patient experienced NECK PAIN (shoulder and neck pain in the mornings), MYALGIA (muscle soreness) and HEADACHE (headaches). At the time of the report, NECK PAIN (shoulder and neck pain in the mornings), JOINT SWELLING (both of his ankles are swelling), PYREXIA (fever for two days), MYALGIA (muscle soreness) and HEADACHE (headaches) outcome was unknown and ARTHRALGIA (elbow and wrist hurt for one day   ) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided  Treatment medications - Epsom salt   This case was linked to MOD-2021-182432 (Patient Link).
Swelling around injections site and pain in left deltoid for approx 24hrs but still lingering at 48hrs.
Information has been received from a physician concerning a male who was vaccinated with a second dose of ROTATEQ (date not specified).  Four days after the patient had received the second dose of ROTATEQ, the patient was hospitalized for intussusception with air reduction.  The dates of hospitalization and patient's outcome were unknown.  No product quality issues were involved.  Additional information has been requested.  1/12/09 Reviewed hospital medical records of 10/13-10/15/2008. FINAL DX: Ileocolic intussusception, enema reduced Records reveal patient experienced irritability, hematemesis, abd distention.  Transferred to PICU from outlying hospital.  Progressed well s/p air enema & d/c to home for PCP f/u.    11/21/08 Reviewed hospital medical records of 10/11-10/13/2008. FINAL DX: abdominal obstruction; sepsis ruled out. Records reveal patient experienced vomiting & change in mental status.  Septic work up neg.  Tx w/IVF & IV antibiotics initially.  Developed persistent vomiting, abdominal pain, hypoactive bowel sounds.  Transferred to higher level of care.
Patient was scheduled for their second dose of Moderna but was administered the Janssen vaccine instead. The patient did not report any side effects.
Experienced swollen armpit and breast lymph nodes a few days prior to April 5, 2021. Around 5pm on April 5, 2021, my injection site felt very sore and I discovered a large red rash around the injection site. It showed up out of nowhere. My left arm is currently more sore and throbbing than when first injected. The pain and throbbing occurs in my left upper neck and radiates down to my fingers in left hand.  My entire arm is incredibly weak.
Tounge is getting numb; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Jul-2021 and was forwarded to Moderna on 29-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Tounge is getting numb) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (Tounge is getting numb). At the time of the report, HYPOAESTHESIA ORAL (Tounge is getting numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Additional information received included vaccine route of administration.
We only had a sore arm from the second shot; This is a spontaneous report from a contactable consumer (patient). A 70-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date for COVID-19 immunization (at the age of 70-year-old) and no adverse reaction was reported. The patient experienced we only had a sore arm from the second shot on an unspecified date. It was reported that, they could help to get more to get vaccinated. Patient only had a sore arm from the second shot and this would give data on any possible side effects so when a booster was recommended, would have this data ready for those who would be hesitant. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101042090 same reporter/drug/AE, different patients
Break through COVID with mild head cold type symptoms.  Developed a cough and have had a continued cough and fatigue.  I believe the vaccine kept me from being seriously ill and needing hospitalization.  Did consult my PCP about continued cough and fatigue and was told that is to be expected and "normal for COVID"  I'm only reporting that at the request of the call from the CDC about my vaccine.
Approximately 5 minutes after vaccine administration (8:14a) patient felt heart palpitations, Heart Rate up to 90, blood pressure 149/98.  At 8:22a blood pressure at 153/98, At 8:37 a Blood pressue at 144/96 Within 30 min (8:43a) patient Heart rate down within normal limits to mid 60s and blood pressure to 130/80 (manually).
Red area about 3 inches below the administered site. Bruising of the bicep muscle on the inside of the arm near the red area.
pt states he started having numbness and tingling in both feet but worse in the left foot and ankle.  He had severe swelling in his feet and the Achilles tendon. (right one was really large) Pt went to a Physical Therapist for the pain where they did  test on his feet and treated with physical rehab.  About three weeks after the vaccine he noticed the pain in other joints like knees, elbows, wrist, and fingers.  Pt went to an Orthopedic clinic for his pain. They did blood work and urine test.  Numbers were high on his  rheumatoid factor at 81H and CCP was 150 A.  He was referred  to a rheumatoid specialist.  His lab numbers still getting higher.  He was treated with Naproxen and Volteran.  He is now on prednisone and Plaquenil.  He will see his RA doctor again next month.  His pain gets so bad that he has to have help getting to the restroom at times and would literally have to crawl to get around.  He is eating better and feeling some better at this point after taking the prednisone.
Pt w/cough, fever, running nose, rash on face to trunk x 2-3 days papular w/blanching; occasional petechia on back recvd MMR 2 wks ago;
Developed widespread severe urticaria10 days  after COVID 19 booster . Treated with antihistamines,  prednisone 20mg for 2 weeks and  injections of dexamethasone for 4 days.  Now with spontaneous chronic urticaria. Rash develops daily with raised erythematous plaques at several body sites that remain for 15-45 minutes before resolving and beginning again later that day in another body site.
DURING ADMINISTRATION, I INJECTED NEEDLE INTO ARM, AND THE NEEDLE IMMEDIATELY EJECTED BACK OUT OF ARM BEFORE VACCINE COULD BE DELIVERED
A few days after vaccine, neck was sore to touch. This lasted about a week and seems to be fine now.  Red rash around the vax area, noticed on 3/15 it has grown bigger, is a bit sore to touch.
My eyes and throat was red and itchy over the counter medicine didn't work and by sept it still didn't go away and I started breaking out in hives. I went to the doctor and prescribed me ALLEGRA and vitamin D. I went a dermatologist and she said it was probably from the COVID-19 shot or from COVID-19. The dermatologist told me to keep taking ALLEGRA and if it got worse to double the dose. I still have the hives and my eyes and throat are still occasionally itchy.
2hr 30min p/vax pt devel tissue swelling 4" diameter from inj site w/extreme pain;sx diminished p/2 days
No additional AE; temperature excursion on VARlVAX; This spontaneous report was received from a medical assistant, referring to a 12-month-old patient. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.   On 08-APR-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # S025911, expiration date 20-AUG-2021, for prophylaxis (dose, vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported).   The vaccine was stored in a temperature of -58 degree Fahrenheit (°F) and +5 °F (6.3F) for 6 Hours 0 Minutes 30 Seconds and at -58 °F and +5 °F (10.9F) for 7 Minutes 30 Seconds as recorded by a data logger.
arm swelled up; was so hot that I could hardly it just felt like it was just literally burning; fluid that had build up under my arm; little bit hot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled up), FEELING HOT (was so hot that I could hardly it just felt like it was just literally burning), FLUID RETENTION (fluid that had build up under my arm) and FEELING HOT (little bit hot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced PERIPHERAL SWELLING (arm swelled up), FEELING HOT (was so hot that I could hardly it just felt like it was just literally burning), FLUID RETENTION (fluid that had build up under my arm) and FEELING HOT (little bit hot). At the time of the report, PERIPHERAL SWELLING (arm swelled up), FEELING HOT (was so hot that I could hardly it just felt like it was just literally burning) and FEELING HOT (little bit hot) had not resolved and FLUID RETENTION (fluid that had build up under my arm) was resolving.            No concomitant medications was reported. Treatment medications was not provided.
This spontaneous report as received from a nurse concerning unspecified number of patients of unknown age and gender. Approximately in 2017 (reported as between 30-MAY-2017 and 16-AUG-2017), the patients were vaccinated with improperly stored ZOSTAVAX vial 19400 PFU (plaque-forming units) lot # M042850 with expiry date: 18-JAN-2018 (dosing details unknown) for prophylaxis. The vaccines were reconstituted with properly stored sterile diluent (lot# unknown). It was reported that the vaccines were exposed to a temperature range of 15F to 46F for a duration of 1 hour. During the previous temperature excursion the vaccines were exposed to a temperature range of 15F to 46F for a duration of 1 hour. Data logger was involved. No adverse effects were reported. There were no product quality complaints. Sender's Comments: US-009507513-1708USA008039: US-009507513-1708USA008040.
swelling of lower lip, no swelling of face. sores present on and around mouth, some sores on the inside as well as on her tongue
Pain, swelling to Lt arm, unable to lift arm. Also pain/swelling under arm.
Loss of taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced AGEUSIA (Loss of taste). At the time of the report, AGEUSIA (Loss of taste) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    The caller is the mother of the patient. She wanted to report side effects of vaccine. She was concerned if her son is positive for COVID-19 infection.
lt leg became 22x nl size, pt was screaming & very uncomfortable;taken to ER by father mom believes OTC DPH was given by 8-10PM;pt appeared fine;MD stated no more pertussis;